Novel oxazolinoanthracyclines as tumor cell growth inhibitors—Contribution of autophagy and apoptosis in solid tumor cells death
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel oxazolinoanthracyclines as tumor cell growth inhibitors—Contribution of autophagy and apoptosis in solid tumor cells death
Authors
Keywords
Autophagic cell death, Apoptosis, Fluorescence microscopy, Membrane potential, Drug therapy, Mitochondrial membrane, Cancer treatment, Cell staining
Journal
PLoS One
Volume 13, Issue 7, Pages e0201296
Publisher
Public Library of Science (PLoS)
Online
2018-07-25
DOI
10.1371/journal.pone.0201296
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ovarian Cancer Follow-up
- (2017) Anne Lanceley et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
- (2017) Jiahui Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Structural modifications in the sugar moiety as a key to improving the anticancer effectiveness of doxorubicin
- (2017) Marta Denel-Bobrowska et al. LIFE SCIENCES
- Cardiotoxicity of anthracycline therapy: current perspectives
- (2016) Mihaela Valcovici et al. Archives of Medical Science
- Daunorubicin Down-Regulates the Expression of Stem Cell Markers and Factors Involved in Stem Cell Migration and Homing in Rat Heart in Subchronic but not Acute Cardiomyopathy
- (2016) Jasna Srankova et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- ROS and ROS-Mediated Cellular Signaling
- (2016) Jixiang Zhang et al. Oxidative Medicine and Cellular Longevity
- Pharmacogenetics of anthracyclines
- (2016) Judit C Sági et al. PHARMACOGENOMICS
- Identification of the key pathway of oxazolinoanthracyclines mechanism of action in cells derived from human solid tumors
- (2016) Marta Denel-Bobrowska et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Progress in systemic therapy of advanced hepatocellular carcinoma
- (2016) Xin-Lei Gong et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Tumor suppressive functions of ceramide: evidence and mechanisms
- (2015) Sehamuddin Galadari et al. APOPTOSIS
- Analysis of redox and apoptotic effects of anthracyclines to delineate a cardioprotective strategy
- (2015) Joy Marie Fulbright et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo
- (2015) JIA LIU et al. ONCOLOGY REPORTS
- Calcium and ROS: A mutual interplay
- (2015) Agnes Görlach et al. Redox Biology
- Stress Responses from the Endoplasmic Reticulum in Cancer
- (2015) Hironori Kato et al. Frontiers in Oncology
- Oxidative stress and autophagy: the clash between damage and metabolic needs
- (2014) G Filomeni et al. CELL DEATH AND DIFFERENTIATION
- Die another way – non-apoptotic mechanisms of cell death
- (2014) Stephen W. G. Tait et al. JOURNAL OF CELL SCIENCE
- Hydrogen peroxide inhibits proliferation and endothelial differentiation of bone marrow stem cells partially via reactive oxygen species generation
- (2014) Yuan Xiao et al. LIFE SCIENCES
- Autophagy prevents doxorubicin-induced apoptosis in osteosarcoma
- (2014) DONGXU ZHAO et al. Molecular Medicine Reports
- Liposomal Nitrooxy-Doxorubicin: One Step over Caelyx in Drug-Resistant Human Cancer Cells
- (2014) Isabella Pedrini et al. MOLECULAR PHARMACEUTICS
- Hydrogen peroxide signaling in vascular endothelial cells
- (2014) Rosa Bretón-Romero et al. Redox Biology
- Calcium and mitochondrial metabolism in ceramide-induced cardiomyocyte death
- (2013) Valentina Parra et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity
- (2012) Balindiwe J.N. Sishi et al. BIOCHEMICAL PHARMACOLOGY
- Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer
- (2012) Miranda Y. Fong et al. PLoS One
- How does doxorubicin work?
- (2012) Anand G Patel et al. eLife
- Caloric Restriction Mimetic 2-Deoxyglucose Antagonizes Doxorubicin-induced Cardiomyocyte Death by Multiple Mechanisms
- (2011) Kai Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells
- (2011) Weidong Han et al. PLoS One
- Dual Role of 3-Methyladenine in Modulation of Autophagy via Different Temporal Patterns of Inhibition on Class I and III Phosphoinositide 3-Kinase
- (2010) You-Tong Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dasatinib synergizes with doxorubicin to block growth, migration and invasion of breast cancer cells
- (2009) C S Pichot et al. BRITISH JOURNAL OF CANCER
- Synthesis and biological properties of oxazolinodaunorubicin—a new derivative of daunorubicin with a modified daunosamine moiety
- (2009) Malgorzata Lukawska et al. INVESTIGATIONAL NEW DRUGS
- Cardiomyocyte H9c2 Cells Exhibit Differential Sensitivity to Intracellular Reactive Oxygen Species Generation with Regard to Their Hypertrophic vs Death Responses to Exogenously Added Hydrogen Peroxide
- (2009) Kyohei Oyama et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now